<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36285345</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Analysis of HTT CAG repeat expansion in Italian patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1820</StartPage><EndPage>1825</EndPage><MedlinePgn>1820-1825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51673</ELocationID><Abstract><AbstractText>HTT full-penetrance pathogenic repeat expansions, the genetic cause of Huntington's disease (HD), have been recently reported in a minority of frontotemporal dementia/amyotrophic lateral sclerosis (ALS) patients (0.13%). We analyzed HTT CAG repeats in an Italian cohort of ALS patients (n&#x2009;=&#x2009;467) by repeat-primed polymerase chain reaction. One patient harbored two expanded alleles in the HTT gene (42 and 37 CAG repeats). The absence of HD typical symptoms and the clinical picture consistent with ALS, corroborated by the diagnostic assessment, apparently excluded a misdiagnosis of HD.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Manini</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gagliardi</LastName><ForeName>Delia</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8460-938X</Identifier><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneri</LastName><ForeName>Megi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antognozzi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Bo</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaglione</LastName><ForeName>Cesa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comi</LastName><ForeName>Giacomo Pietro</ForeName><Initials>GP</Initials><Identifier Source="ORCID">0000-0002-1383-5248</Identifier><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Neuromuscular and Rare Diseases Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corti</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5425-969X</Identifier><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronchi</LastName><ForeName>Dario</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6093-9816</Identifier><AffiliationInfo><Affiliation>Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="Y">Huntington Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>RDB, GPC, and SC are members of the FALS Sequencing Consortium. The other authors declare no existing conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>2</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36285345</ArticleId><ArticleId IdType="pmc">PMC9639631</ArticleId><ArticleId IdType="doi">10.1002/acn3.51673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Dewan R, Chia R, Ding J, et&#xa0;al. Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron. 2021;109(3):448&#x2010;460.e4. https://linkinghub.elsevier.com/retrieve/pii/S0896627320308837
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864894</ArticleId><ArticleId IdType="pubmed">33242422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner SL, Boogaard MW, Trompet S, et&#xa0;al. Prevalence of carriers of intermediate and pathological polyglutamine disease&#x2013;associated alleles among large population&#x2010;based cohorts. JAMA Neurol. 2019;76(6):650. doi:10.1001/jamaneurol.2019.0423</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.0423</ArticleId><ArticleId IdType="pmc">PMC6563569</ArticleId><ArticleId IdType="pubmed">30933216</ArticleId></ArticleIdList></Reference><Reference><Citation>Peplow M. The 100,000 genomes project. BMJ. 2016;i1757. doi:10.1136/bmj.i1757</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i1757</ArticleId><ArticleId IdType="pubmed">27075170</ArticleId></ArticleIdList></Reference><Reference><Citation>
Thomas Q, Coarelli G, Heinzmann A, Le Ber I, Amador MM, Durr A. Questioning the causality of HTT CAG&#x2010;repeat expansions in FTD/ALS. Neuron. 2021;109(12):1945&#x2010;1946. https://linkinghub.elsevier.com/retrieve/pii/S0896627321002609
</Citation><ArticleIdList><ArticleId IdType="pubmed">34139183</ArticleId></ArticleIdList></Reference><Reference><Citation>
Thion MS, T&#xe9;zenas du Montcel S, Golmard J&#x2010;L, et&#xa0;al. CAG repeat size in Huntingtin alleles is associated with cancer prognosis. Eur J Hum Genet. 2016;24(9):1310&#x2010;1315. http://www.nature.com/articles/ejhg201613
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4989202</ArticleId><ArticleId IdType="pubmed">26980106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J&#x2010;M, Ramos EM, Lee J&#x2010;H, et&#xa0;al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78(10):690&#x2010;695. doi:10.1212/WNL.0b013e318249f683</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318249f683</ArticleId><ArticleId IdType="pmc">PMC3306163</ArticleId><ArticleId IdType="pubmed">22323755</ArticleId></ArticleIdList></Reference><Reference><Citation>
Paulsen JS, Miller AC, Hayes T, Shaw E. Cognitive and behavioral changes in Huntington disease before diagnosis. Handb Clin Neurol. 2017;144:69&#x2010;91. https://linkinghub.elsevier.com/retrieve/pii/B9780128018934000067
</Citation><ArticleIdList><ArticleId IdType="pubmed">28947127</ArticleId></ArticleIdList></Reference><Reference><Citation>Coudert L, Nonaka T, Bernard E, Hasegawa M, Schaeffer L, Leblanc P. Phosphorylated and aggregated TDP&#x2010;43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models. Cell Mol Life Sci. 2019;76(13):2615&#x2010;2632. doi:10.1007/s00018-019-03059-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03059-8</ArticleId><ArticleId IdType="pubmed">30863908</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips O, Squitieri F, Sanchez&#x2010;Castaneda C, et&#xa0;al. The corticospinal tract in Huntington's disease. Cereb Cortex. 2015;25(9):2670&#x2010;2682. doi:10.1093/cercor/bhu065</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhu065</ArticleId><ArticleId IdType="pubmed">24706734</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2000;1(5):293&#x2010;299. doi:10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>
Jama M, Millson A, Miller CE, Lyon E. Triplet repeat primed PCR simplifies testing for Huntington disease. J Mol Diagn. 2013;15(2):255&#x2010;262. https://linkinghub.elsevier.com/retrieve/pii/S152515781200308X
</Citation><ArticleIdList><ArticleId IdType="pubmed">23414820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A, Magri S, Salvatore E, et&#xa0;al. Frequency and distribution of polyQ disease intermediate&#x2010;length repeat alleles in healthy Italian population. Neurol Sci. 2020;41(6):1475&#x2010;1482. doi:10.1007/s10072-019-04233-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04233-3</ArticleId><ArticleId IdType="pubmed">31940111</ArticleId></ArticleIdList></Reference><Reference><Citation>Capiluppi E, Romano L, Rebora P, et&#xa0;al. Late&#x2010;onset Huntington's disease with 40&#x2013;42 CAG expansion. Neurol Sci. 2020;41(4):869&#x2010;876. doi:10.1007/s10072-019-04177-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04177-8</ArticleId><ArticleId IdType="pmc">PMC7160095</ArticleId><ArticleId IdType="pubmed">31820322</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer B, Goldberg P, Andrew SE, et&#xa0;al. A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994;330(20):1401&#x2010;1406. doi:10.1056/NEJM199405193302001</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199405193302001</ArticleId><ArticleId IdType="pubmed">8159192</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso M, Yescas P, Rasmussen A, et&#xa0;al. Homozygosity in Huntington's disease: new ethical dilemma caused by molecular diagnosis. Clin Genet. 2002;61(6):437&#x2010;442. doi:10.1034/j.1399-0004.2002.610607.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0004.2002.610607.x</ArticleId><ArticleId IdType="pubmed">12121351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cubo E, Martinez&#x2010;Horta S&#x2010;I, Santalo FS, et&#xa0;al. Clinical manifestations of homozygote allele carriers in Huntington disease. Neurology. 2019;92. doi:10.1212/WNL.0000000000007147</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007147</ArticleId><ArticleId IdType="pubmed">30867264</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Wheelock V, Benatar M, et&#xa0;al. A case of familial ALS due to multi&#x2010;system proteinopathy 1 and Huntington disease. Amyotroph Lateral Scler Front Degener. 2015;16(1&#x2013;2):124&#x2010;126. doi:10.3109/21678421.2014.952238</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.952238</ArticleId><ArticleId IdType="pmc">PMC4664522</ArticleId><ArticleId IdType="pubmed">25205077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman RA, Dewan R, Cortes E, et&#xa0;al. Amyotrophic lateral sclerosis is over&#x2010;represented in two Huntington's disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion. Acta Neuropathol. 2022;143(1):105&#x2010;108. doi:10.1007/s00401-021-02385-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02385-1</ArticleId><ArticleId IdType="pmc">PMC8918027</ArticleId><ArticleId IdType="pubmed">34800149</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bernard E, Mouzat K, Leblanc P, et&#xa0;al. Amyotrophic lateral sclerosis in Huntington disease gene carrier. Rev Neurol. 2017;173(10):670&#x2010;671. https://linkinghub.elsevier.com/retrieve/pii/S0035378716302016
</Citation><ArticleIdList><ArticleId IdType="pubmed">28595974</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AL, Teener JW, Callaghan BC, Harrington J, Uhlmann WR. Amyotrophic lateral sclerosis in a patient with a family history of huntington disease: genetic counseling challenges. J Genet Couns. 2014;23(5):725&#x2010;733. doi:10.1007/s10897-014-9715-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10897-014-9715-6</ArticleId><ArticleId IdType="pubmed">24763861</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio A, Steinberg K, Figlewicz DA, et&#xa0;al. Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathol. 1996;92(4):421&#x2010;427. doi:10.1007/s004010050539</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050539</ArticleId><ArticleId IdType="pubmed">8891076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M, Coon EA, Osmand AP, et&#xa0;al. Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol. 2012;124(5):749&#x2010;760. doi:10.1007/s00401-012-1005-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1005-5</ArticleId><ArticleId IdType="pmc">PMC3545711</ArticleId><ArticleId IdType="pubmed">22735976</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper&#x2010;Knock J, Shaw PJ, Kirby J. The widening spectrum of C9ORF72&#x2010;related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol. 2014;127(3):333&#x2010;345. doi:10.1007/s00401-014-1251-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1251-9</ArticleId><ArticleId IdType="pmc">PMC3925297</ArticleId><ArticleId IdType="pubmed">24493408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensman Moss DJ, Poulter M, Beck J, et&#xa0;al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 2014;82(4):292&#x2010;299. doi:10.1212/WNL.0000000000000061</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000061</ArticleId><ArticleId IdType="pmc">PMC3929197</ArticleId><ArticleId IdType="pubmed">24363131</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>